Gilead Sciences (GILD) Revenue — Quarter Ended Sep 30, 2023
Revenue for the quarter increased compared to the prior quarter, while remaining nearly flat compared to the same period last year. The sequential growth reflects a continuation of the upward trend from the preceding quarter.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue for the quarter increased compared to the prior quarter, while remaining nearly flat compared to the same period last year. The sequential growth reflects a continuation of the upward trend from the preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$7.1B
Revenue reported for this quarter.
Quarter-over-quarter
+6.8%
Change from the immediately preceding quarter.
Year-over-year
+0.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$27.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $7.4B | +2.0% |
| Mar 31, 2023 | $6.4B | -3.6% |
| Jun 30, 2023 | $6.6B | +5.4% |
| Sep 30, 2023 | $7.1B | +0.1% |
Revenue performance
The quarter saw a sequential revenue increase after a decline in the first quarter of the fiscal year. The revenue level was essentially unchanged from the prior year.
Quarterly comparison
Compared to the immediately preceding quarter, revenue rose. Compared to the same quarter one year earlier, revenue was virtually unchanged.
What to watch
The company's operating cash flow for the first nine months of the fiscal year decreased compared to the same period in the prior year, as noted in the filing.